The29F.1A12monoclonalantibodyreactswithmousePD-1(programmeddeath-1)alsoknownasCD279.PD-1isa50-55kDacellsurfacereceptorencodedbythePdcd1genethatbelongstotheCD28familyoftheIgsuperfamily.PD-1istransientlyexpressedonCD4andCD8thymocytesaswellasactivatedTandBlymphocytesandmyeloidcells.PD-1expressiondeclinesaftersuccessfuleliminationofantigen.Additionally,Pdcd1mRNAisexpressedindevelopingBlymphocytesduringthepro-B-cellstage.PD-1’sstructureincludesaITIM(immunoreceptortyrosine-basedinhibitorymotif)suggestingthatPD-1negativelyregulatesTCRsignals.PD-1signalsviabindingitstwoligands,PD-L1andPD-L2bothmembersoftheB7family.Uponligandbinding,PD-1signalinginhibitsT-cellactivation,leADIngtoreducedproliferation,cytokineproduction,andT-celldeath.Additionally,PD-1isknowntoplaykeyrolesinperipheraltoleranceandpreventionofautoimmunediseaseinmiceasPD-1knockoutanimalsshowdilatedcardiomyopathy,splenomegaly,andlossofperipheraltolerance.InducedPD-L1expressioniscommoninmanytumorsincludingsquamouscellcarcinoma,colonadenocarcinoma,andbreastadenocarcinoma.PD-L1overexpressionresultsinincreasedresistanceoftumorcellstoCD8Tcellmediatedlysis.Inmousemodelsofmelanoma,tumorgrowthcanbetransientlyarrestedviatreatmentwithantibodieswhichblocktheinteractionbetweenPD-L1anditsreceptorPD-1.Forthesereasonsanti-PD-1mediatedimmunotherapiesarecurrentlybeingexploredascancertreatments.LiketheRMP1-14andJ43antibodiesthe29F.1A12antibodyhasbeenshowntoblockthebindingofPD-1toitsligandsinvivo.
| Isotype | RatIgG2a |
| RecomendedIsotypeControl(s) | InVivoPlusratIgG2aisotypecontrol,anti-trinitrophenol |
| RecommendedInVivoPureDilutionBuffer | InVivoPurepH7.0DilutionBuffer |
| Immunogen | RecombinantPD-1-Igfusionprotein |
| ReportedApplications |
|
| Endotoxin |
|
| Purity |
|
| Aggregation |
|
| Formulation |
|
| Sterility | 0.2μMfiltered |
| Production | Purifiedfromtissueculturesupernatantinananimalfreefacility |
| Purification | ProteinG |
| Storage | Undilutedat4°Cinthedark |
| MurinePathogenTestResults |
|
